Revolution Medicines, Inc. (RVMD) stock
RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
$159.82−2.87 (-1.76%)
Close on Nov 18, 2026Market cap $34.26BP/E –Yield –
Revolution Medicines EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Revolution Medicines
Revolution Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?